Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

India · Delayed Price · Currency is INR

4,309.30

-59.90 (-1.37%)

Mar 4, 2026, 1:20 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Generic Formulation Business	115.16B	107.28B	96.20B	85.08B	80.05B
Generic Formulation Business Growth	7.35%	11.51%	13.07%	6.29%	0.82%
Total	115.16B	107.28B	96.20B	85.08B	80.05B
Total Growth	7.35%	11.51%	13.07%	6.29%	0.82%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	67.88B	61.09B	53.70B	46.83B	40.29B
India Growth	11.10%	13.78%	14.66%	16.22%	5.04%
Brazil	11.00B	11.26B	9.35B	7.42B	6.30B
Brazil Growth	-2.29%	20.38%	26.07%	17.75%	-11.81%
United States	11.00B	10.78B	11.62B	10.67B	12.63B
United States Growth	2.05%	-7.26%	8.89%	-15.52%	-17.08%
Germany	11.39B	10.74B	9.28B	9.66B	10.39B
Germany Growth	6.09%	15.77%	-4.00%	-6.96%	9.69%
Other Countries	13.89B	13.41B	12.25B	10.49B	10.43B
Other Countries Growth	3.60%	9.40%	16.78%	0.59%	13.58%
Total	115.16B	107.28B	96.20B	85.08B	80.05B
Total Growth	7.35%	11.51%	13.07%	6.29%	0.82%

Source: S&P Global Market Intelligence.